First-Ever Blood-Stage Vaccine For Malaria Shows Promising Results In Phase IIb Trial
The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.
Positive interim Phase IIb data shows promise of first blood-stage malaria vaccine
A blood-stage malaria vaccine would not replace pre-erythrocytic vaccines, but provide a second line of defence.
Taiwan News14 天
Saudi Arabia Malaria Vaccine Market Application, Product Segment, Analysis and Forecast ...
Request To Download Free Sample of This Strategic Report @ The Saudi Arabia Malaria Vaccine Market presents a dynamic landscape shaped by the prevalence of malaria in the region, coupled with ongoing ...
eLife17 天
PfMORC protein regulates chromatin accessibility and transcriptional repression in the ...
Department of Molecular, Cell and Systems Biology, University of California Riverside, Riverside, USA Stowers Institute for Medical Research, Kansas City, USA ...
Nature18 天
Malaria articles from across Nature Portfolio
Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...
eLife27 天
A system for functional studies of the major virulence factor of malaria parasites
This study introduces an important approach using selection linked integration (SLI) to generate Plasmodium falciparum lines expressing single, specific surface adhesins PfEMP1 variants, enabling ...